The ET/LA and bladder cancer cell line systems also showed significant differences, with higher ROS levels seen in the mesenchymal cell lines/variants (ET/LA, 2.6-fold, p = 0.0160; TSU-Pr1/B2, 2.7-fold, p = 0.0284). This evidence concerns the gene TMEM37 and urinary bladder cancer.